(Bloomberg) -- Novo Nordisk A/S will restrict initial sales of its blockbuster obesity treatment Wegovy in China, as the drugmaker grapples with how to control access to the medicine for the world ...

It was not clear when Wegovy would be formally launched in China, where Novo Nordisk's sales rose by 11 percent last year at constant exchange rates. Its patent in the world's second-most populous ...

Novo Nordisk disclosed it knows of 10 deaths and 100 hospitalizations from people taking compounded copies of its weight loss ...

We look at China’s probe into AstraZeneca ... For a preview of the anito-cel data, look here. Wegovy shows potential as a treatment for MASH Novo Nordisk weight loss drug Wegovy has shown ...

The company narrowed its full-year guidance as its blockbuster weight-loss drug soars in popularity.

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...

As corporations like Microsoft, Dell, Stanley Black & Decker, Blizzard Entertainment, and Airbnb pull back on China, dozens of others are shifting their global footprints, sighting everything from ...

Unfortunately, the economic choices China is making look set to promote greater repression at home and increased tension with neighbors and trading partners around the world.

China offers multiple visa-free travel policies to foreigners, enabling people from a wide range of countries to visit China on a short-term basis. In this article, we provide an overview of all of ...

China’s highly anticipated Finance Ministry briefing on Saturday lacked the firepower that equity investors had hoped for, indicating that the volatility that’s gripped the market following a ...

To understand today's headlines about China's approach to issues such as trade, foreign policy or internet censorship, turn to its past. The country is perhaps more aware of its own history than ...

Novo Nordisk (NYSE:NVO) – Novo Nordisk announced the approval of Wegovy in China, initially planning to market it to patients who can afford the weekly injectable treatment. While facing ...